FBRX

NASDAQ Healthcare

Forte Biosciences, Inc.

$76.99

(+0.00%)

Live quote

52w: $10.11 – $77.20

Loading chart…

P/E Ratio—

P/B Ratio25.44

EV/EBITDA—

Debt/Equity—

ROE-164.79%

ROIC—

Revenue Growth-99.80%

Gross Margin—

Forte Biosciences, Inc. is a U.S.-based biopharmaceutical company currently in its clinical development phase. The firm's key initiative involves advancing the FB-102 program, which is designed to tackle a variety of autoimmune conditions, notably vitiligo and alopecia areata. Their main offices are situated in Dallas, Texas.

Own FBRX? Track it here.

Create a free account to add FBRX to a portfolio and watch your P/L update in real time.

Custom screens, valuation models and backtesting are coming to Pro.

Create a free account